ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 78 filers reported holding ITEOS THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $2,975,146 | -30.5% | 218,600 | -0.2% | 0.01% | -33.3% |
Q4 2022 | $4,278,945 | -49.0% | 219,096 | -50.3% | 0.02% | -11.8% |
Q3 2022 | $8,392,372 | +23.4% | 440,564 | +33.5% | 0.02% | +30.8% |
Q2 2022 | $6,798,330 | -51.8% | 330,032 | -24.6% | 0.01% | -35.0% |
Q1 2022 | $14,093,551 | +38.2% | 437,946 | +100.0% | 0.02% | -23.1% |
Q4 2021 | $10,195,000 | +74.5% | 218,971 | +1.2% | 0.03% | +62.5% |
Q3 2021 | $5,842,000 | -45.4% | 216,357 | -48.1% | 0.02% | +6.7% |
Q2 2021 | $10,690,000 | +152.8% | 416,776 | +236.9% | 0.02% | +15.4% |
Q1 2021 | $4,228,000 | – | 123,702 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM ASSET MANAGEMENT LLC | 2,738,785 | $29,989,696 | 16.06% |
MPM BioImpact LLC | 1,745,943 | $19,118,076 | 5.10% |
Saturn V Capital Management LP | 994,756 | $10,892,578 | 4.56% |
Boxer Capital, LLC | 1,804,058 | $19,754,435 | 1.05% |
RA Capital Management | 4,417,259 | $48,368,986 | 0.95% |
683 Capital Management, LLC | 810,000 | $8,869,500 | 0.69% |
Ikarian Capital, LLC | 346,471 | $3,793,857 | 0.46% |
Ikarian Capital, LLC | 3,056 | $3,346,320 | 0.40% |
BVF INC/IL | 1,259,476 | $13,791,262 | 0.37% |
DAFNA Capital Management LLC | 98,560 | $1,079,232 | 0.34% |